Recently identified and potential targets for colon cancer treatment
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recently identified and potential targets for colon cancer treatment
Authors
Keywords
-
Journal
Future Oncology
Volume 6, Issue 6, Pages 993-1002
Publisher
Future Medicine Ltd
Online
2010-06-08
DOI
10.2217/fon.10.53
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
- (2010) Peter M. Wilson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
- (2010) S. S. Sikandar et al. CANCER RESEARCH
- Case–control study on beneficial effect of regular consumption of apples on colorectal cancer risk in a population with relatively low intake of fruits and vegetables
- (2010) Wieslaw Jedrychowski et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- The Evolving Role of Monoclonal Antibodies in Colorectal Cancer: Early Presumptions and Impact on Clinical Trial Development
- (2010) C. Eng ONCOLOGIST
- Advances in the Treatment of Metastatic Colorectal Cancer
- (2009) Carla Kurkjian et al. AMERICAN JOURNAL OF THERAPEUTICS
- Evolving Treatment of Advanced Colon Cancer
- (2009) Neil H. Segal et al. Annual Review of Medicine
- Acquired vorinostat resistance shows partial cross-resistance to ‘second-generation’ HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities
- (2009) Konstantin J. Dedes et al. ANTI-CANCER DRUGS
- Colon cancer and the elderly: From screening to treatment in management of GI disease in the elderly
- (2009) Peter R. Holt et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines
- (2009) Laetitia Dahan et al. BRITISH JOURNAL OF PHARMACOLOGY
- The potential role and application of PARP inhibitors in cancer treatment
- (2009) A. J. Chalmers BRITISH MEDICAL BULLETIN
- Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate
- (2009) Muthusamy Thangaraju et al. CANCER
- Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
- (2009) Brenda K. Edwards et al. CANCER
- HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer Cells
- (2009) Xufeng Chen et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1
- (2009) M. Sachdeva et al. CANCER RESEARCH
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
- (2009) P. Wang et al. CANCER RESEARCH
- Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance
- (2009) Yu-Ying Chen et al. CANCER SCIENCE
- Chemotherapy for operable and advanced colorectal cancer
- (2009) Carlo Aschele et al. CANCER TREATMENT REVIEWS
- Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
- (2009) M. S. Banck et al. CLINICAL CANCER RESEARCH
- A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer
- (2009) M. G. Fakih et al. CLINICAL CANCER RESEARCH
- Three DNA Methylation Epigenotypes in Human Colorectal Cancer
- (2009) K. Yagi et al. CLINICAL CANCER RESEARCH
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
- (2009) R. N. Jorissen et al. CLINICAL CANCER RESEARCH
- Chemotherapy options and outcomes in older adult patients with colorectal cancer
- (2009) Muhammad W. Saif et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
- (2009) G. Bar-Sela et al. CURRENT MEDICINAL CHEMISTRY
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair geneMSH2
- (2009) Sarah A. Martin et al. EMBO Molecular Medicine
- APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the ApcMin mouse model in vivo
- (2009) Stewart Sale et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells
- (2009) Pedro M. Borralho et al. FEBS Journal
- Cancers colorectaux avant et après les biothérapies : une révolution dans la prise en charge des patients ?
- (2009) P. Rougier et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Epigenetic regulation of microRNA expression in colorectal cancer
- (2009) Eva Bandres et al. INTERNATIONAL JOURNAL OF CANCER
- Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells
- (2009) William Fazzone et al. INTERNATIONAL JOURNAL OF CANCER
- Die medikamentöse Therapie des kolorektalen Karzinoms
- (2009) A. Reinacher-Schick et al. INTERNIST
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel
- (2009) Changxing Liu et al. JOURNAL OF CONTROLLED RELEASE
- The antiangiogenic effect of thalidomide on occult liver metastases: Anin vivostudy in mice
- (2009) Yi Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
- (2009) Raffaele Baffa et al. JOURNAL OF PATHOLOGY
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
- (2009) Salvatore Siena et al. JNCI-Journal of the National Cancer Institute
- MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
- (2009) Ondrej Slaby et al. Molecular Cancer
- A Novel Inhibitor of DNA Polymerase Enhances the Ability of Temozolomide to Impair the Growth of Colon Cancer Cells
- (2009) A. S. Jaiswal et al. MOLECULAR CANCER RESEARCH
- Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models
- (2009) T. M. Pitts et al. MOLECULAR CANCER THERAPEUTICS
- Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft
- (2009) M. Kaur et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms
- (2009) T. Walker et al. MOLECULAR PHARMACOLOGY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic Role of Curcumin With Current Therapeutics in Colorectal Cancer: Minireview
- (2009) Bhaumik B. Patel et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer
- (2009) C.-H. Kohne et al. ONCOLOGIST
- 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells
- (2009) Choi ONCOLOGY REPORTS
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Adjuvant therapy for colon cancer: Present and perspectives
- (2008) S. De Dosso et al. CANCER TREATMENT REVIEWS
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now